Kyoto company founded in 2019 developing regenerative medical products, including a kidney disease treatment program.
Rege Nephro Co., Ltd., doing business as Rege Nephro, was founded in 2019 and operates from Kyoto, Japan, developing regenerative medical products. Its products serve healthcare providers, rehabilitation centers and consumers in Japan and select parts of Asia. In July 2021 it raised JPY 480 million in venture funding from TaiAn Technologies. Planned use of its July 2026 funds includes clinical preparation for its kidney disease treatment program.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in